Today

Agents

Chat

Arena

Discover

More

App

Supernus Pharmaceuticals Q2 EPS USD -1.01 - SUPN News | Rallies

Supernus Pharmaceuticals Q2 EPS USD -1.01

SUPN•2026-08-03

Q2 results

Aug. 3 (Reuters) - Supernus Pharmaceuticals Q2 product sales were USD 165.7 million.

Q2 adjusted revenue: USD 201.1 million
Q2 operating earnings: USD -57.963 million
Q2 adjusted operating earnings: USD 31.2 million vs. IBES estimate USD 18.9 million

Related News

HUB Cyber Security regains compliance with Nasdaq $35 million market value listing rule

HUBC•2026-08-03

Marriott falls on Q3 profit forecast below estimates

MAR•2026-08-03

Tyson trims annual profit forecast as tight cattle supplies squeeze beef business

•

2026-08-03

BridgeBio Pharma to report Q2 financial results, provide business update on conference call

BBIO•2026-08-03

Street View: Strength in AbbVie's immunology pipeline to support revenue growth

ABBV•2026-08-03